Combination Photodynamic Therapy and Anti-Vascular Endothelial Growth Factor for Recalcitrant Chronic Central Serous Chorioretinopathy

被引：0
|
作者：
Chon, Andrew T. [1 ,2 ]
Asahi, Masumi George [1 ,2 ]
Gallemore, Ron P. [1 ]
Wallsh, Joshua [1 ]
机构：
[1] Retina Macula Inst, Ophthalmol, Clin Res, Torrance, CA USA
[2] Western Univ Hlth Sci, Pomona, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5930
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy
    Arevalo, J. Fernando
    Espinoza, Juan V.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (01) : 403 - 404
  • [2] Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy
    J. Fernando Arevalo
    Juan V. Espinoza
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 403 - 404
  • [3] ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY VERSUS PHOTODYNAMIC THERAPY IN THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO CENTRAL SEROUS CHORIORETINOPATHY
    Peiretti, Enrico
    Caminiti, Giulia
    Serra, Rita
    Querques, Lea
    Pertile, Riccardo
    Querques, Giuseppe
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (08): : 1526 - 1532
  • [4] Treatment of central serous chorioretinopathy using anti-vascular endothelial growth factor
    Abdelghani, Wael
    Ramos, Elmira
    Tawfik, Hebatullah
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [5] Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy
    Smretschnig, E.
    Hagen, S.
    Glittenberg, C.
    Ristl, R.
    Krebs, I.
    Binder, S.
    Ansari-Shahrezaei, S.
    EYE, 2016, 30 (06) : 805 - 811
  • [6] Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy
    E Smretschnig
    S Hagen
    C Glittenberg
    R Ristl
    I Krebs
    S Binder
    S Ansari-Shahrezaei
    Eye, 2016, 30 : 805 - 811
  • [7] Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis
    Lu, H. Q.
    Wang, E. Q.
    Zhang, T.
    Chen, Y. X.
    EYE, 2016, 30 (01) : 15 - 22
  • [8] Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis
    H Q Lu
    E Q Wang
    T Zhang
    Y X Chen
    Eye, 2016, 30 : 15 - 22
  • [9] Photodynamic therapy for central serous chorioretinopathy with choroidal neovascularization on optical coherence tomography angiography combined with intravitreal anti-vascular endothelial growth factor therapy or alone
    Sonoda, Nao
    Araki, Takashi
    Komuku, Yuki
    Iwami, Hisashi
    Gomi, Fumi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [10] The Uses of Photodynamic Therapy Versus Anti-vascular Endothelial Growth Factor in the Management of Acute Central Serous Chorioretinopathy: A Systematic Review and Meta-Analysis
    Seraj, Hadeel
    Alhamoud, Mustafa
    Khoshhal, Mohammed S.
    Alhashim, Hassan
    Alsaif, Anas
    Abukhashabah, Amro
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
12345